Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 596,829 | 667,694 | 892,478 | 264,930 | 589,529 |
| Marketable Securities | 204,541 | 153,386 | 194,455 | 254,308 | N/A |
| Receivables | 8,732 | 8,389 | 9,981 | 7,737 | 7,731 |
| TOTAL | $828,574 | $845,454 | $1,114,760 | $541,326 | $608,497 |
| Non-Current Assets | |||||
| PPE Net | 137,675 | 123,496 | 55,323 | 54,772 | 54,896 |
| Investments And Advances | 188,629 | 142,166 | 45,944 | 15,599 | 16,887 |
| Intangibles | 6,759 | 6,531 | 5,439 | 4,191 | 3,856 |
| Other Non-Current Assets | 2,145 | 1,571 | 1,453 | 1,396 | 1,401 |
| TOTAL | $335,208 | $273,764 | $108,159 | $75,958 | $77,040 |
| Total Assets | $1,163,781 | $1,119,218 | $1,222,919 | $617,284 | $685,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 78,829 | 25,013 | 67,401 | 52,628 | 38,564 |
| Other current liabilities | 306 | 27,126 | 261 | N/A | 378 |
| TOTAL | $87,920 | $60,318 | $75,315 | $59,868 | $46,130 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 107,983 | 100,840 | 35,201 | 32,033 | 33,934 |
| TOTAL | $107,983 | $100,840 | $35,201 | $32,033 | $33,934 |
| Total Liabilities | $195,903 | $161,158 | $110,516 | $91,901 | $80,065 |
| Shareholders' Equity | |||||
| Common Shares | 8,714 | 8,244 | 8,384 | 7,147 | 7,108 |
| Retained earnings | -1,317,805 | -1,176,887 | -1,041,945 | -847,376 | -744,263 |
| Other shareholders' equity | 190,416 | 151,955 | 138,576 | 119,139 | 104,729 |
| TOTAL | $967,879 | $958,060 | $1,112,403 | $525,383 | $605,471 |
| Total Liabilities And Equity | $1,163,781 | $1,119,218 | $1,222,919 | $617,284 | $685,536 |